HSA Approval

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

Approval Number

SIN15952P

Drug Name

Product Name

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

Approval Date

June 12, 2020

Registrant

HETERO SINGAPORE PTE. LTD.

Licence Holder

HETERO SINGAPORE PTE. LTD.

Regulatory Information

Registrant

HETERO SINGAPORE PTE. LTD.

Licence Holder

HETERO SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

N01BB02

ATC Item Name

lidocaine

Manufacturer Information

Pharmaceutical Manufacturer

HETERO SINGAPORE PTE. LTD.

Manufacturers

Aspiro Pharma Limited

Active Ingredients

Ingredient Name

Lidocaine Hydrochloride

Strength

50mg/5ml

Drug MonographLidocaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML - HSA Approval | MedPath

AI-Powered Research

Premium Access

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal